Christoph Schaefers

Christoph Schaefers holds the position of Clinical Assistant Professor at the II. Medical Clinic and Polyclinic, part of the Faculty of Medicine at the University of Hamburg. His primary affiliation is with the Center for Oncology at the Universitätsklinikum Hamburg-Eppendorf (UKE). His clinical expertise focuses on hematology and oncology, particularly in the treatment of malignant blood disorders such as multiple myeloma, lymphoma, and germ cell tumors. Dr. Schaefers is actively involved in translational research, investigating novel therapeutic approaches including CAR-T cell therapies, bispecific antibodies, and immunotherapeutic strategies for relapsed/refractory cancers. His work emphasizes real-world clinical outcomes, treatment protocols, and the molecular mechanisms underlying cancer progression.

His research spans a range of topics, including the efficacy of BCMA-targeted therapies, splicing-driven cancer mechanisms, and the impact of viral infections (e.g., Hepatitis E) on immunocompromised patients. He has contributed to international multicenter studies on germ cell tumors and Burkitt lymphoma, leveraging nationwide registry data for epidemiological insights. Dr. Schaefers collaborates with interdisciplinary teams to address challenges in healthcare infrastructure for advanced cancer therapies.

Publications highlight his focus on clinical trials, biomarker discovery, and improving patient outcomes through precision medicine. His work bridges basic science and clinical practice, with a particular emphasis on pediatric and young adult populations. The Center for Oncology provides a collaborative environment for advancing oncological care and research.